ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Hereditary angioedema and other forms of nonhistaminergic angioedema

Society guideline links: Hereditary angioedema and other forms of nonhistaminergic angioedema

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Urticaria and angioedema (excluding hereditary angioedema)".)

International

World Allergy Organization (WAO)/European Academy of Allergy and Clinical Immunology (EAACI): International guideline for the management of hereditary angioedema – The 2021 revision and update (published 2022)

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency (2016)

Hereditary Angioedema International Working Group: Consensus report on classification, diagnosis, and approach to treatment for angioedema (2014)

International Consensus (ICON): Hereditary and acquired angioedema (2012)

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency (2012)

Canada

Canadian Hereditary Angioedema Network (CHAEN): The international/Canadian hereditary angioedema guideline (2019)

United States

American Academy of Emergency Medicine (AAEM): Clinical practice statement – What is the emergency department management of patients with angioedema secondary to an ACE-inhibitor? (2021)

US Hereditary Angioedema Association (US HAEA): Guidelines for the management of hereditary angioedema, 2020 (published 2021)

Joint Task Force on Practice Parameters (JTFPP): A focused parameter on hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema, update (2013)

Europe

World Allergy Organization (WAO)/European Academy of Allergy and Clinical Immunology (EAACI): International guideline for the management of hereditary angioedema – The 2021 revision and update (published 2022)

United Kingdom

United Kingdom consensus document on C1 inhibitor deficiency, 2014 (published 2015)

Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Urtricaria/angio-oedema/mastocytosis (2011)

Australia–New Zealand

Australasian Society of Clinical Immunology and Allergy (ASCIA): Hereditary angioedema (HAE) position paper, update (2022)

Japan

Japanese Association for Complement Research (JACR): Guideline for hereditary angioedema (HAE) – Secondary publication, 2010 (published 2012)

Topic 104440 Version 14.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟